Skip to content
StockMarketAgent
Sector pending / Orthopedic, Prosthetic, and Surgical Appliances and SuppliesUpdated 2026-05-10 22:07 UTC

FRA/2X7 stock hub

FRA/2X7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/2X7is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
388.6M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/2X7FRA/2X7
Loading chart…
In the news

Latest news · FRA/2X7

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-11.6
P25 n/aP50 n/aP75 n/a
ROIC-3.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/2X7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
168
Groups with data
11
Currency
USD
Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
602
Employees Change
315%
Employees Change Percent
127.5
Enterprise value
EUR 442.5M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Last refreshed
2026-05-10
Market cap
EUR 388.6M
Price
EUR 14.4
Price currency
EUR
Rev Per Employee
350,520.3x
Sic
3842
Symbol
fra/2X7
Website
https://www.orthopediatrics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-8.85%
EV Earnings
-12.86x
EV/FCF
-40.41x
EV/Sales
2.14x
FCF yield
-2.82%
P/B ratio
1.32x
P/S ratio
1.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-10.85%
EBITDA Margin
-1.89%
Gross margin
73.07%
Gross Profit
EUR 154.2M
Gross Profit Growth
14.94%
Gross Profit Growth Q
13.4%
Gross Profit Growth3 Y
22.95%
Gross Profit Growth5 Y
24.62%
Net Income
EUR -34.4M
Pretax Margin
-16.27%
Profit Margin
-16.31%
Profit Per Employee
EUR -57,161
ROA
-3.39
Roa5y
-3.75
ROCE
-5.8
ROE
-11.57
Roe5y
-6.77
ROIC
-3.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
-23.42%
Cagr3y
-30.11%
Cagr5y
-22.2%
Revenue Growth
14.52x
Revenue Growth Q
13.26x
Revenue Growth3 Y
23.09x
Revenue Growth5 Y
26.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
EUR 0.5
Assets
EUR 435.5M
Cash
EUR 42.3M
Current Assets
EUR 208.5M
Current Liabilities
EUR 40M
Debt
EUR 97.3M
Debt EBITDA
EUR 1,320
Debt Equity
EUR 0.33
Debt FCF
EUR -8.89
Equity
EUR 293.8M
Interest Coverage
-3.79
Liabilities
EUR 141.8M
Long Term Assets
EUR 227.1M
Long Term Liabilities
EUR 101.8M
Net Cash
EUR -55M
Net Cash By Market Cap
EUR -14.15
Net Debt Equity
EUR 0.19
Tangible Book Value
EUR 127.3M
Tangible Book Value Per Share
EUR 4.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.21
Inventory Turnover
0.52
Net Working Capital
EUR 131.9M
Quick ratio
2.19
Working Capital
EUR 172.3M
Working Capital Turnover
EUR 1.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-23.4%
200-day SMA
15.24
3Y total return
-65.88%
50-day SMA
14.11
50-day SMA vs 200-day SMA
50under200
5Y total return
-71.49%
All Time High
62.5
All Time High Change
-76.96%
All Time High Date
2021-11-08
All Time Low
12.3
All Time Low Change
17.07%
All Time Low Date
2026-04-30
ATR
0.35
Ch YTD
-2.7
High
14.4
High52
21
High52 Date
2025-05-13
High52ch
-31.43%
Low
14.4
Low52
12.3
Low52 Date
2026-04-30
Low52ch
17.07%
Ma50ch
2.04%
Price vs 200-day SMA
-5.53%
RSI
57.58
RSI Monthly
37.28
RSI Weekly
46.65
Sharpe ratio
-0.54x
Sortino ratio
-0.65
Total Return
-1.69%
Tr YTD
-2.7
Tr1m
6.67%
Tr1w
11.63%
Tr3m
3.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -22.9M
Operating margin
-10.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
15,904,639%
Net Borrowing
19,916,083.5
Shares Insiders
5.77%
Shares Institutions
60.99%
Shares Qo Q
0.46%
Shares Yo Y
1.69%
Short Ratio
5.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
EUR -26.5M
Average Volume
0x
Bv Per Share
11.47
CAPEX
EUR -7.5M
Ch1m
6.67
Ch1w
11.63
Ch1y
-23.4
Ch3m
3.6
Ch3y
-65.88
Ch5y
-71.49
Ch6m
2.86
Change
0.7%
Change From Open
0
Close
14.3
Days Gap
0.7
Depreciation Amortization
18,478,787.9
Earnings Date
2026-04-30
EBIT
EUR -22.9M
EBITDA
EUR -4M
EPS
EUR -1.46
F Score
3
FCF
EUR -10.9M
FCF EV Yield
-2.47x
Financing CF
20,370,275
Fiscal Year End
December
Founded
2,006
Goodwill
97,662,327.4
Income Tax
EUR 80,659
Investing CF
-35,931,372
Is Primary Listing
0
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Ma150
14.57
Ma150ch
-1.17%
Ma20
13.65
Ma20ch
5.53%
Net CF
-18,372,883
Open
14.4
Ppne
41,171,946.9
Price Date
2026-05-08
Ptbv Ratio
3.05
Relative Volume
20x
Revenue
211,013,223x
SBC By Revenue
7.36x
Share Based Comp
15,525,537
Tax By Revenue
0.04x
Tr6m
2.86%
Volume
0
Z Score
1.76
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/2X7 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2X7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-23.4%
S&P 500 1Y: n/a
3Y total return
-65.9%
S&P 500 3Y: n/a
5Y total return
-71.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/2X7?

Insider, institutional, and short-interest positioning.

Institutional ownership
+61.0%
Share of float held by funds and institutions
Insider ownership
+5.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
5.6 days to cover
Y/Y dilution
+1.7%
Negative means the company is buying back shares.
Technical

FRA/2X7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
57.6
Neutral momentum band
Price vs 200-day MA
-5.5%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.54
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/2X7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2X7 stock rating?

fra/2X7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2X7 analysis?

The full report lives at /stocks/fra/2X7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2X7?

The latest report frames fra/2X7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2X7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.